Company news
Applied Biocode Corp. (TWSE:6598) news
Applied Biocode Corp. news releases on 6ix. Latest, Aug 11, 2026: Applied BioCode Reports Record Financial Results for the First Half of 2026; Revenue…
Press releases & updates
Applied BioCode Reports Record Financial Results for the First Half of 2026; Revenue Increases 81% Year Over Year, Driven by Strong U.S. Molecular Diagnostics Growth
August 11, 2026
Applied BioCode Announces New Nucleic Acid Extraction Claim for KingFisher™ Flex Nucleic Acid Purification System with BioCode® Gastrointestinal Pathogen Panel (GPP)
January 14, 2025
Applied BioCode Announces the Launch of the STI + Resistance Panel Assay for Research Use Only
April 15, 2024
Applied BioCode Announces Retirement of CEO Chris Bernard
March 21, 2024
Applied BioCode Appoints Industry Veteran Beth Laderman as Chief Scientific Officer
September 28, 2023
Applied BioCode Announces the Launch of the Fungal Panel Assay for Research Use
June 12, 2023
Applied BioCode Announces Distribution Agreement with Medline Industries
May 8, 2023
Applied BioCode Announces 2022 Q4 and Full year Revenue
February 27, 2023
Applied BioCode : Announced the Company's Board Elected Chairperson
June 22, 2022
Applied BioCode : Announced the Appointment of Remuneration Committee Members resolved by the Board of Directors
June 22, 2022
Applied BioCode : The Company's Election of directors at the Company's 2022 Shareholders' General Meeting
June 13, 2022
Applied BioCode : Important resolutions of the Company's 2022 Shareholders' General Meeting
June 13, 2022
Applied BioCode : Announcement the Term Expired of Company's Remuneration Committee Members Due to the Election of Directors
June 13, 2022
Applied BioCode : Announcement the Change of the Company's Audit Committee Members
June 13, 2022
Applied BioCode : Announced the Company's 2022 Shareholders' General Meeting resolved the Release of non-compete restriction for newly elected directors
June 13, 2022
Applied BioCode : Announcement on behalf of subsidiary, Applied BioCode, Inc., signed an amended license and supply agreement with IDEXX Technologies GmbH
May 27, 2022
Applied BioCode : The Company's Board of Directors resolved to convene the 2022 Annual General Shareholders' Meeting (Location confirmed and electronic voting period amended)
April 28, 2022
Applied BioCode : At the request of TWSE, the Company announce related financial information
April 11, 2022
Applied BioCode Appoints Industry Veteran Chris Bernard as Chief Executive Officer
March 24, 2022
Applied BioCode Announces Exclusive Partner Distribution Agreement with Hardy Diagnostics, Further Broadens Reach of BioCode® MDx-3000 System into Hospitals and Reference Laboratories in the United States
March 14, 2022
Applied BioCode Obtains Emergency Use Authorization for CoV-2 Flu Plus Assay
December 16, 2021
Applied BioCode Launches 28 New Fungal Analyte Specific Reagents in the US
November 22, 2021
Applied BioCode : Receives Emergency Use Authorization for Pooled COVID-19 Testing
December 10, 2020
Applied BioCode : Submits FDA 510(k) Application for Syndromic BioCode® Respiratory Pathogen Panel
September 11, 2019